Lipid-lowering Agent Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 77948 | Published Date: Oct 2024 | No. of Page: 110 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL LIPID-LOWERING AGENT INDUSTRY
    2.1 Summary about Lipid-lowering Agent Industry
    2.2 Lipid-lowering Agent Market Trends
        2.2.1 Lipid-lowering Agent Production & Consumption Trends
        2.2.2 Lipid-lowering Agent Demand Structure Trends
    2.3 Lipid-lowering Agent Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Niaci
        4.2.2 Acipimox
        4.2.3 Fibrates
        4.2.4 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Hospitals
        4.3.2 Clinics
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Niaci
        5.2.2 Acipimox
        5.2.3 Fibrates
        5.2.4 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Hospitals
        5.3.2 Clinics
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Niaci
        6.2.2 Acipimox
        6.2.3 Fibrates
        6.2.4 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Hospitals
        6.3.2 Clinics
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Niaci
        7.2.2 Acipimox
        7.2.3 Fibrates
        7.2.4 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Hospitals
        7.3.2 Clinics
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Niaci
        8.2.2 Acipimox
        8.2.3 Fibrates
        8.2.4 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Hospitals
        8.3.2 Clinics
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Niaci
        9.2.2 Acipimox
        9.2.3 Fibrates
        9.2.4 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Hospitals
        9.3.2 Clinics
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Pfizer
        10.1.2 Merck
        10.1.3 Teva
        10.1.4 Amgen
        10.1.5 Abbott
        10.1.6 AstraZeneca
        10.1.7 Novartis
        10.1.8 SUN Pharma
        10.1.9 Torrent Pharmaceuticals
        10.1.10 GlaxoSmithKline
        10.1.11 HanAll BioPharma
        10.1.12 JX Pharmaceuticals
        10.1.13 Aurobindo Pharma
        10.1.14 Abbvie
        10.1.15 Cerenis Therapeutics
    10.2  Lipid-lowering Agent Sales Date of Major Players (2017-2020e)
        10.2.1 Pfizer
        10.2.2 Merck
        10.2.3 Teva
        10.2.4 Amgen
        10.2.5 Abbott
        10.2.6 AstraZeneca
        10.2.7 Novartis
        10.2.8 SUN Pharma
        10.2.9 Torrent Pharmaceuticals
        10.2.10 GlaxoSmithKline
        10.2.11 HanAll BioPharma
        10.2.12 JX Pharmaceuticals
        10.2.13 Aurobindo Pharma
        10.2.14 Abbvie
        10.2.15 Cerenis Therapeutics
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Lipid-lowering Agent Product Type Overview
Table Lipid-lowering Agent Product Type Market Share List
Table Lipid-lowering Agent Product Type of Major Players
Table Brief Introduction of Pfizer
Table Brief Introduction of Merck
Table Brief Introduction of Teva
Table Brief Introduction of Amgen
Table Brief Introduction of Abbott
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Novartis
Table Brief Introduction of SUN Pharma
Table Brief Introduction of Torrent Pharmaceuticals
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of HanAll BioPharma
Table Brief Introduction of JX Pharmaceuticals
Table Brief Introduction of Aurobindo Pharma
Table Brief Introduction of Abbvie
Table Brief Introduction of Cerenis Therapeutics
Table Products & Services of Pfizer
Table Products & Services of Merck
Table Products & Services of Teva
Table Products & Services of Amgen
Table Products & Services of Abbott
Table Products & Services of AstraZeneca
Table Products & Services of Novartis
Table Products & Services of SUN Pharma
Table Products & Services of Torrent Pharmaceuticals
Table Products & Services of GlaxoSmithKline
Table Products & Services of HanAll BioPharma
Table Products & Services of JX Pharmaceuticals
Table Products & Services of Aurobindo Pharma
Table Products & Services of Abbvie
Table Products & Services of Cerenis Therapeutics
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Lipid-lowering Agent Market Forecast (Million USD) by Region 2021f-2026f
Table Global Lipid-lowering Agent Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Lipid-lowering Agent Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Lipid-lowering Agent Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Lipid-lowering Agent Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Lipid-lowering Agent Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Lipid-lowering Agent Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Lipid-lowering Agent Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Lipid-lowering Agent Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Lipid-lowering Agent Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Lipid-lowering Agent Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Niaci Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Acipimox Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Fibrates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Niaci Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Acipimox Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Fibrates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Niaci Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Acipimox Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Fibrates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Niaci Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Acipimox Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Fibrates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Niaci Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Acipimox Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Fibrates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Niaci Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Acipimox Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Fibrates Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Merck 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Teva 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Amgen 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Abbott 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of AstraZeneca 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of SUN Pharma 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Torrent Pharmaceuticals 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of HanAll BioPharma 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of JX Pharmaceuticals 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Aurobindo Pharma 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Abbvie 2017-2020e
Figure Lipid-lowering Agent Sales Revenue (Million USD) of Cerenis Therapeutics 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Lipid-lowering Agent Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lipid-lowering Agent Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lipid-lowering Agent Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports